SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
NRXP

NRX Pharmaceuticals, Inc. (NASDAQ:NRXP)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$2.22-$0.06 (-2.63%)
 
Market cap
$96.1M
Insider Score
Health Score
Analyst consensus
Listed since
Dec 4, 2017
Insider Score
––Not scored
NRXP Insider Score

No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.

NRXP analyst forecast

NRXP analyst consensus

Moderate Buy3 ratings
Buy 3 Hold 0 Sell 0

Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.

NRXP 12-month price target

No published price targets in the last 12 months.

Best analysts covering NRXP

  • Ascendiant Capital67%success rate · +13.0% avg return · 6 calls
  • D. Boral Capital65%success rate · +13.0% avg return · 23 calls
  • HC Wainwright & Co.22%success rate · -10.4% avg return · 9 calls

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

NRXP analyst ratings

FirmPrice targetAction
—BTIGBuy——Reiterated2026-11-11
—Ascendiant CapitalBuy——Reiterated2026-11-02
—HC Wainwright & Co.Buy——Reiterated2026-08-25
—D. Boral CapitalBuy——Reiterated2026-05-05

NRXP earnings vs. estimates

QuarterEPS est.EPS actualRevenue est.Revenue actual
2025-11-17-$0.11-$0.27$6.1M$242K
2026-03-23-$0.09$0.19$7.5M$983K
2026-05-15-$0.05-$0.04$19.4M$1.1M
2026-08-17-$0.11-$0.44$1.3M$1.1M
2026-11-16Upcoming-$0.21—$1.3M—
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.